Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS

NCT06008093

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Beverly Hills, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
View all 47 locations
View Trial Details
Active, not recruiting

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

NCT02193282

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 1407 locations
View Trial Details
Active, not recruiting

Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC

NCT04227028

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Active, not recruiting

Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

NCT04655976

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Walnut Creek, California, United States
  • GSK Investigational Site Norwich, Connecticut, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
View all 163 locations
View Trial Details
Active, not recruiting

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

NCT05925530

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site The Bronx, New York, United States
  • Research Site Houston, Texas, United States
  • Research Site Charlottesville, Virginia, United States
  • Research Site Vienna, Austria
View all 49 locations
View Trial Details
Active, not recruiting

Avelumab Program Rollover Study

NCT03815643

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +32 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California Davis Health System - Comprehensive Cancer Center Sacramento, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 104 locations
View Trial Details
Active, not recruiting

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01)

NCT05478538

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • James M Stockman Cancer Institute Frederick, Maryland, United States
  • New York Cancer & Blood Specialists Shirley, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Active, not recruiting

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

NCT05091567

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta, Georgia, United States
  • Illinois Cancer Care Peoria, Illinois, United States
  • New England Cancer Specialists Scarborough, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 95 locations
View Trial Details
Active, not recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions
Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Salinas Valley Memorial Healthcare System Salinas, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Memorial Health System Pembroke Pines, Florida, United States
View Trial Details

Related conditions